[Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol
Adrenergní beta-blokáda nadololem v lécbĕ tyreotoxikózy.